REAMBERIN 1.5%

· POLYSAN Scientific & Technological Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REAMBERIN 1.5%, covering 2025-06-24 to 2025-06-24. Get the full timeline:

Most recent: Clinical Trial Update: REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis [Phase 2, Phase 3]